Tanshinone IIA Improves Intestinal Barrier Integrity in Septic Rats.

Area of Science:

• Pharmacology
• Sepsis Pathophysiology
• Gastroenterology

Background:

• Sepsis significantly compromises intestinal barrier integrity, leading to increased permeability and systemic inflammation.
• Intestinal dysfunction is a critical factor in sepsis-induced organ damage and mortality.
• Tanshinone IIA, a compound from Salvia miltiorrhiza, has shown anti-inflammatory and antioxidant properties.

Purpose of the Study:

• To investigate the protective effects of tanshinone IIA on the intestinal barrier during sepsis.
• To elucidate the underlying molecular mechanisms, particularly the role of the PXR-CYP3A4 pathway.

Main Methods:

• Sepsis was induced in rats using cecal ligation and puncture (CLP); tanshinone IIA was administered intraperitoneally.
• Intestinal permeability, oxidative stress markers (MDA, SOD), inflammatory cytokines (IL-1β, TNF-α), and apoptosis were assessed.
• Histopathology, immunofluorescence, and immunoblotting were used to evaluate tissue damage and protein expression.
• In vitro studies used Caco-2 cells stimulated with lipopolysaccharide (LPS) to assess PXR and CYP3A4 levels.

Main Results:

• Tanshinone IIA dose-dependently reduced intestinal permeability, bacterial translocation, and ileum histological damage in septic rats.
• It attenuated markers of oxidative stress and inflammation (MDA, IL-1β, TNF-α) while increasing antioxidant capacity (SOD).
• Tanshinone IIA restored the expression of tight junction proteins (claudin-1, JAM, occludin, ZO-1) and suppressed apoptosis.
• In vitro, tanshinone IIA normalized PXR and CYP3A4 levels in LPS-stimulated Caco-2 cells.

Conclusions:

• Tanshinone IIA demonstrates significant protective effects against intestinal injury in a murine model of sepsis.
• The mechanism involves the activation of the PXR-CYP3A4 pathway in intestinal epithelial cells, enhancing barrier function and reducing inflammation.